To investigate the effect of a Dutch Can Do Training (CDT) on self-efficacy in people with Relapsing Remitting Multiple Sclerosis.
ID
Source
Brief title
Condition
- Demyelinating disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Self-efficacy-control, as measured by the Multiple Sclerosis Self-Efficacy-18
control score.
Secondary outcome
Self-efficacy-function, MSSES-18 (function score); Problem-related autonomy,
Impact on Participation and Autonomy (IPA-32) problem-related score;
Limitations-related autonomy, IPA-32 limitations-score; health-related quality
of life, Multiple Sclerosis Quality of Life-54 (MSQoL-54) questionnaire (mental
and physical scores); anxiety and depression, Hospital Anxiety and Depression
Scale-14 (HADS-14) (anxiety and depression scores); cost effectiveness and cost
utility, EQ-5D-5L, costs questionnaire; neurological symptoms and handicap,
Expanded Disability Status Scale (EDSS) (only 1 week before CDT).
Background summary
In people with MS (PwMS) symptoms and disabilities often negatively affect
self-reliance. As a result many PwMS loose their self-efficacy and autonomy.
Importantly, loss of self-efficacy and autonomy has been shown to result in a
decrease in health-related quality of life. One of the consequences of these
developments is that PwMS do more appeal to their partners or care givers.
In the U.S.A. a program (Can Do Training, CDT) has been developed that offers
PwMS a way to regain their capabilities and self-efficacy. It consists of an
intensive training given by a multidisciplinary team of health care
professionals.
In a 12-month pilot study we investigated the feasibility and potential
effectiveness of modified Dutch version of CDT. This CDT variant consists of a
3-day training (in contrast to the 5-day program in the U.S.A.) and also
includes the partners of the PwMS.The available data indicate that this CDT
program is fasible, as of the 97 participants only 7 (7%) discontinued the
training prematurely. However, for PwMS who had recently been diagnosed the CDT
turned out to be (too) confronting due to the presence in the groups of people
with advanced disease and disability. We also noticed an evident need of CDT in
PwMS with no partner.
Moreover, an analysis (N=44) of the 6-month data showed statistically
significant differences between participants with relatively few symptoms and
limitations (Expanded Disability Status Scale [EDSS] score <4,0) vs. those with
more symptoms and limitations (EDSS score >4,0), and also between participants
with Relapsing Remitting MS (RRMS) vs. those with progressive MS. In the
EDSS<4,0-group and the RRMS group significant improvements were seen in various
outcomes, whereas in the EDSS>4,0-group and the progressive group no
improvements were seen. The Multiple Sclerosis Self-Efficacy-Control (MSSE-C)
score in the EDSS<4,0-group had increased by 17,3% (mean) and in the RRMS group
with 24,8% (mean). In addition, in the RRMS group the mental Multiple Sclerosis
Quality of Life-54 Items (MSQoL-54) score had increased by 22,3% (mean) and the
physical MSQoL-54 score by 12,7% (mean).
Study objective
To investigate the effect of a Dutch Can Do Training (CDT) on self-efficacy in
people with Relapsing Remitting Multiple Sclerosis.
Study design
In the periode from April to December 2013 5 CDTs will be given in weekends,
one CDT per weekend. Per CDT a control group will be formed that receives no
CDT. Both groups complete questionnaires at the same time points. The time
points are: one week before CDT, 1 month after CDT and 3 and 6 momths after
CDT.
Participants will be randomized.
Primary endpoint is the Multiple Sclerosis Self-Efficacy-18 control score.
Intervention
CDT consists of training programs tailored to the personalized goals of the
individual participants. The training is given by a team of experienced healh
care professionals (neurologisct, MS-specialized nurse, psychiater, psychiatric
nurse, physiotherapist, yga teacher). The aim of the training exercises is to
explore the personal limits and thus to increase one's capabilities related to
the individual goal, which can be physical or mental.
Study burden and risks
Burden and risk.
For PwMS in the CDT group: During CDT the participants explore their limits by
goal-oriented, individualized, tailored and intensive mental or physical
exercices. It has been known that PwMS may experience a temporary worsening of
symptoms (e.g. fatigue) after intensive physical of mental strains. These
changes do not result from an increase in inflammation, completely disappear
after rest, and constitute a so-called pseudo-relapse. A true relapse is only
related to stress in as far it is mental, negative and chronic.
Confrontation with one's limitations and handicaps might illicit new or intense
emotions. These situations are immediately recognized by the CDT team and
adequately handled.
For PwMS in both groups: The strain related to the completion of the
questionnaires is considered moderate as there are 4 time points in a 6-month
period, the completion per time point is 70 minutes at maximum, and the
questionnaires are MS-relevant.
For partners in the CDT group: During CDT the participants explore their limits
by goal-oriented, individualized, tailored and intensive mental or physical
exercices. To prevent this group from setting unrealistic goals, that might
potentially affect their health, the partners are counseled by the team CDT
members.
For partners in both groups: The burden related to the completion of
thequestionnaires is minimal: 4 times in a 6-month period, with less than 20
minutes per time.
Risk for all participants: as the activities may be strenuous accidents might
happen, e.g. when walking through a forets.
Benefit
PwMS may regain lost capabilities and reconquer their autonomy and improve
health-related quality of life, whereas they may rebalance the relation with
their partners regarding autonomy (PwMS) and care-related stress (partners).
Wagenstraat 25
Maassluis 3142 CR
NL
Wagenstraat 25
Maassluis 3142 CR
NL
Listed location countries
Age
Inclusion criteria
For people with multiple sclerosis (MS): 1) diagnosis Relapsing Remitting MS since 1 year or longer, 2) Expanded Disability Status Scale (EDSS) score less than or equal to 4.0, 3) no symptoms suggestive of a relapse, 4) no relapse in the previous 4 weeks, 5) willing and capable to participate in the investigations mentioned in the study protocol.
For partners of people with MS: willing and capable to participate in the investigations mentioned in the study protocol.
Exclusion criteria
1) Progressive type of multiple sclerosis (MS), 2) Diagnosis MS since less than 1 year, 3) Expanded Disability Status Scale (EDSS) score less higher than 4.0, 4) Symptoms suggestive of a relapse, 5) Relapse in last 4 weeks, 6) not capable to participate in the investigations mentioned in the study protocol.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL42205.028.12 |
OMON | NL-OMON25770 |